Newton-Bishop JA - Search Results

1

POT1 loss-of-function variants predispose to familial melanoma.

Robles-Espinoza CD, Harland M, Ramsay AJ, Aoude LG, Quesada V, Ding Z, Pooley KA, Pritchard AL, Tiffen JC, Petljak M, Palmer JM, Symmons J, Johansson P, Stark MS, Gartside MG, Snowden H, Montgomery GW, Martin NG, Liu JZ, Choi J, Makowski M, Brown KM, Dunning AM, Keane TM, López-Otín C, Gruis NA, Hayward NK, Bishop DT, Newton-Bishop JA, Adams DJ. Robles-Espinoza CD, et al. Nat Genet. 2014 May;46(5):478-481. doi: 10.1038/ng.2947. Epub 2014 Mar 30. Nat Genet. 2014. PMID: 24686849 Free PMC article.

2

Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype.

Newton Bishop JA, Bataille V, Pinney E, Bishop DT. Newton Bishop JA, et al. Melanoma Res. 1994 Aug;4(4):199-206. doi: 10.1097/00008390-199408000-00001. Melanoma Res. 1994. PMID: 7950355

3

Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations.

Pollock PM, Spurr N, Bishop T, Newton-Bishop J, Gruis N, van der Velden PA, Goldstein AM, Tucker MA, Foulkes WD, Barnhill R, Haber D, Fountain J, Hayward NK. Pollock PM, et al. Hum Mutat. 1998;11(6):424-31. doi: 10.1002/(SICI)1098-1004(1998)11:6<424::AID-HUMU2>3.0.CO;2-2. Hum Mutat. 1998. PMID: 9603434

4

The genetics of melanoma: the UK experience.

Newton Bishop JA, Harland M, Bishop DT. Newton Bishop JA, et al. Clin Exp Dermatol. 1998 Jul;23(4):158-61. doi: 10.1046/j.1365-2230.1998.00344.x. Clin Exp Dermatol. 1998. PMID: 9894359 Review.

5

Mutation testing in melanoma families: INK4A, CDK4 and INK4D.

Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT. Newton Bishop JA, et al. Br J Cancer. 1999 Apr;80(1-2):295-300. doi: 10.1038/sj.bjc.6690354. Br J Cancer. 1999. PMID: 10390011 Free PMC article.

6

Mutation screening of the CDKN2A promoter in melanoma families.

Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarrà G, Goldstein AM, Tucker MA, Ponder BA, Mann GJ, Bishop DT, Newton Bishop J. Harland M, et al. Genes Chromosomes Cancer. 2000 May;28(1):45-57. Genes Chromosomes Cancer. 2000. PMID: 10738302

7

Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study.

Wachsmuth RC, Gaut RM, Barrett JH, Saunders CL, Randerson-Moor JA, Eldridge A, Martin NG, Bishop TD, Newton Bishop JA. Wachsmuth RC, et al. J Invest Dermatol. 2001 Aug;117(2):348-52. doi: 10.1046/j.0022-202x.2001.01415.x. J Invest Dermatol. 2001. PMID: 11511314 Free article.

8

An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.

Bertram CG, Gaut RM, Barrett JH, Pinney E, Whitaker L, Turner F, Bataille V, Dos Santos Silva I, J Swerdlow A, Bishop DT, Newton Bishop JA. Bertram CG, et al. J Invest Dermatol. 2002 Oct;119(4):961-5. doi: 10.1046/j.1523-1747.2002.01825.x. J Invest Dermatol. 2002. PMID: 12406345 Free article.

9

An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype.

Bertram CG, Gaut RM, Barrett JH, Randerson-Moor J, Whitaker L, Turner F, Bataille V, dos Santos Silva I, Swerdlow AJ, Bishop DT, Newton Bishop JA. Bertram CG, et al. J Invest Dermatol. 2004 Feb;122(2):429-32. doi: 10.1046/j.0022-202X.2003.12541.x. J Invest Dermatol. 2004. PMID: 15009726 Free article.

10

Intronic sequence variants of the CDKN2A gene in melanoma pedigrees.

Harland M, Taylor CF, Bass S, Churchman M, Randerson-Moor JA, Holland EA, Mann GJ, Bishop DT, Newton Bishop JA. Harland M, et al. Genes Chromosomes Cancer. 2005 Jun;43(2):128-36. doi: 10.1002/gcc.20177. Genes Chromosomes Cancer. 2005. PMID: 15761864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page